We studied the effects of angiotensin II (A II) infusion, with and without inhibition of prostaglandin (PG) synthesis, on the determinants of glomerular ultrafiltration in 27 plasma volumeexpanded Munich-Wistar rats. The effects of PG inhibition alone and infusion of vehicle alone also were investigated. With a pressor dose of A II single nephron (SN) GFR and total GFR did not change significantly, despite declines in both glomerular plasma flow rate (QA) and the ultrafiltration coefficient (Kf), due to an offsetting rise in the transcapillary hydraulic pressure difference (AP). Afferent and efferent arteriolar resistances (RA and RE) increased by ~100% above control during A II infusion.
THERE is strong evidence to suggest a functional interaction between the vasoactive hormones angiotensin II (A II) and the prostaglandins (PGs). For example, A II infusion stimulates the synthesis and release of PGs both by the kidney 1 " 3 and in other vascular beds, 4 ' 5 and this enhanced synthesis of PGs appears to attenuate the vasoconstrictor actions of A II in vascular beds where the PGs normally vasodilate. 1 '" Furthermore, agents such as indomethacin and meclofenamate, which inhibit PG synthesis, 6 prevent PG release in response to A II infusion, thus potentiating the vasoconstrictor actions of A II. 4 ' 7 -8 Both AII and PGs exert important hemodynamic influences on the kidney. 9 " 13 In recent studies, we have also shown that exogenous PGE] reduces the glomerular capillary ultrafiltration coefficient, Kf, by some as yet undefined mechanism. 13 Blantz and co-workers 11 reported a similar effect of A II on K f in the volume-expanded Munich-Wistar rat. In earlier experiments on hydropenic rats from this lab-890 CIRCULATION RESEARCH VOL. 43, No. 6, DECEMBER 1978 oratory, 9 ' 10 the persistence of filtration pressure equilibrium during A II infusion prevented calculation of unique values of Kf. These earlier studies therefore did not detect the A II-induced fall in Kf which was apparent in the volume-expansion-induced state of filtration pressure disequilibrium. 11 The present studies were undertaken, in the volume-expanded Munich-Wistar rat, to investigate the effects of exogenous A II administration on the determinants of glomerular ultrafiltration, both with and without prior inhibition of PG synthesis, so as to assess possible interactions between A II and PG on glomerular function in vivo. These experiments also enabled us to examine further the effect of A II on Kf in rats in the volume-expanded state.
Methods
Micropuncture studies were performed on 27 adult male Munich-Wistar rats weighing 205-315 g and allowed free access to water and a standard rat pellet diet. Rats were anesthetized with Inactin (100 mg/kg, ip), placed on a temperature-regulated table, and prepared for micropuncture as described previously. 14 The left and right jugular veins and left femoral artery and vein were catheterized with PE50 polyethylene tubing. The left ureter was catheterized with PE50 polyethylene tubing to allow collection of urine. During these preparative procedures, an iv infusion of 0.9% NaCl solution (at 1.2 ml/hr) was maintained to minimize surgical fluid losses. After surgery was completed, all rats were volume-expanded by infusion of homologous rat plasma (total volume = 2.5% body weight) over a period of 60 minutes. This was followed by an infusion of inulin in 0.9% NaCl solution (4 g/100 ml), given at a rate of 1% body weight per hour, and continued throughout the experiment to maintain the volume-expanded state. In addition, a separate infusion of 0.9% NaCl solution (at 0.5 ml/hr) was initiated as a "volume control" for the subsequent infusion of PG synthetase inhibitor. After a 30-to 45-minute equilibration period, exactly timed (1-2 minutes), samples of tubule fluid were collected from surface proximal convolutions of two or three nephrons for determination of flow rate and inulin concentration. These measurements permit calculation of single nephron glomerular filtration rate (SNGFR) as described previously; 14 inulin concentration in tubule fluid was measured by the method of Vurek and Pegram. 15 In addition, samples of blood from two or three superficial efferent arterioles were obtained as described previously 16 and were analyzed for total protein concentration by a microadaptation 16 of the method of Lowry et al. 17 Samples of femoral arterial plasma were analyzed similarly, thus providing a measure of preglomerular protein concentration. From these measurements of protein concentration (C) in afferent and efferent arteriolar plasma (C A and C E , respectively), values for afferent and effer-ent arteriolar oncotic pressure, n A and n E , were calculated. 18 In addition, these measurements of C A and CE permitted calculation of single nephron filtration fraction (SNFF) and initial glomerular plasma flow rate, Q A , using equations described elsewhere. 14 Mean hydraulic pressures were measured within superficial glomerular capillaries, PGC, as well as in surface proximal tubules, PT, and peritubular capillaries, Pc, by means of the servo-null micropipette transducer technique of Wiederhielm et al. 19 Mean femoral arterial blood pressure, AP, was monitored continually throughout each experiment with an electronic transducer (P23Db, Statham Instruments) connected to a direct writing recorder (model 7702B, Hewlett-Packard). From these measurements it was possible to calculate the mean net transcapillary hydraulic pressure difference across the glomerular capillary wall, AP, (equal to PGC -PT). Also, from the measured decline in hydraulic pressure along single afferent (AP -PGC) and efferent (PGC -Pc) arterioles, together with the calculated blood flow rates through these vessels, it was possible to calculate resistances to blood flow of single afferent and efferent arterioles, R A and RE, respectively. Equations used in calculation of R A and R E , as well as total arteriolar resistance, R™ (equal to R A + RE), were described previously. 14 In view of the volume-expanded state of the rats in the present study, filtration pressure disequilibrium obtained in nearly all animals. This condition enables calculation of unique values for the ultrafiltration coefficient, K f , according to equations described previously; 20 in the few rats that remained at filtration pressure equilibrium after volume expansion only minimum values for Kf were ascertained. 20 During all micropuncture measurements, which usually lasted between 30 and 45 minutes, samples of urine and femoral arterial blood were obtained for estimation of inulin concentration employing the macroanthrone method of Fiihr et al. 21 Immediately after completion of these control measurements, one of the following four protocols was adopted:
Group 1. Time/Volume Control
In a group of six rats [mean body weight, 250 ± 9 (SE) g], a priming infusion of 0.5 ml of NaCl-Na 2 CO 3 solution (0.88% NaCl and 0.2% Na 2 CO 3 , pH 8) was given over a period of 10 minutes, followed by infusion of this same solution at a rate of 0.5 ml/hr for the remainder of the experiment. This procedure was undertaken in group 1 (and 2) rats to provide a volume control for group 3 and 4 experiments, in which PG inhibitor was infused at the same rate, in a vehicle of NaCl and Na 2 CO 3 . Seventy-five minutes after initiation of the NaCl-Na 2 CO 3 infusion, collections of tubule fluid (recollections), systemic and efferent^ arteriolar blood samples, and measurements of AP, P G c, PT, and Pc A n AND PG INTERACTIONS ON GLOMERULAR DYNAMICS/BayZis and Brenner 891 were repeated, as described above for the control period.
Group 2. Infusion of A II
In a second group of seven rats (average body weight, 271 ± 12 g), an infusion of NaCl-Na 2 CO 3 was begun, as described for group 1, immediately after completion of control micropuncture measurements.
Sixty minutes later, angiotensin II amide, A II (Hypertensin, Ciba) was infused, iv, at a rate of 0.2-0.6 ftg/kg per min (A II concentration = 25 /xg of deionized H 2 O per ml; infusion rate, 0.090-0.162 ml/hr). Following a 15-minute equilibration period, during which AP rose by an average of ~30 mm Hg and stabilized at this new level, repeat measurements were made of all determinants of single nephron and microvascular function, as described for group 1.
Group 3. A l l Infusion and PG Inhibition
Inhibition of PG synthesis was achieved in a third group of seven rats (mean body weight, 266 ± 14 g) by infusion of sodium meclofenamate, M (Parke, Davis; n = 3), or indomethacin, I (Merck Sharp and Dohme; n = 4), in a dose of 2 mg/kg per hr (at a rate of 0.5 ml/hr) for the remainder of the experiment. This infusion was preceded by an initial prime of 2 mg of M or I per kg, given over 10 minutes.
Sixty minutes after starting infusion of the PG inhibitor, an iv infusion of A II, identical to that described for group 2, also was begun. Following a 15-minute equilibration period, measurements of all determinants of single nephron and microvascular function were repeated, as described for group 1.
Group 4. PG Inhibition Alone
In a separate group of seven rats (mean body weight, 252 ± 12 g), PG inhibition was achieved exactly as described for group 3 rats. After 75 minutes of M or I infusion, measurements made in the control period were repeated, as described for group 1.
Results

Measurements Made during Control Period in Groups 1-4
Mean data for the initial study period for each group of plasma volume-expanded rats are summarized in Table 1 . As shown, mean values for SNGFR were similar, averaging 49.0 ± 2.5, 47.0 ± 2.8, 50.9 ± 2.7, and 45.1 ± 3.8 nl/min for rats in groups 1-4, respectively. Although not shown, whole kidney GFR was also similar among the four groups, averaging 1.40 ± 0.04, 1.31 ± 0.05, 1.29 ± 0.07, and 1.23 ± 0.09 ml/min. Glomerular plasma flow rate, QA, was also similar among the four groups of rats studied, ranging from 137.0 ± 7.9 to 164.7 ± 18.9 nl/min ( Table 1 ). In addition, the mean value of SNFF was similar among the four groups.
Mean values for AP and PGC ranged from 110 ± 2 to 114 ± 2 mm Hg and from 49 ± 1 to 51 ± 1 mm Hg (Table 1) . Values for PT were also similar, averaging from 13 ± 1 to 15 ± 2 mm Hg. Therefore, although not shown, mean values for AP were similar, averaging 36 ± 1, 35 ± 1, 36 ± 1, and 37 ± 1 mm Hg (groups 1-4; P > 0.05 between all groups). Mean values for Pc were also similar, as shown in Table 1 , as were values for C A and n A . Average values for C E ranged from 7.8 ± 0.2 to 8.3 ± 0.2 g/100 ml and were not significantly different from group to group. n E ranged between 30.5 ± 1.5 and 33.7 ± 0.8 mm Hg. For aU_groups, the average value for IIE was lower than AP, as evidenced by ratios of IIE/AP significantly less than unity for each group (P < 0.05). This inequality between n E and AP, indicating the condition of filtration pressure disequilibrium, obtained in most rats from each group (Table 1) . Under disequilibrium conditions, it is possible to calculate the exact value of the mean net driving pressure for ultranltration, and this value is required for calculation of an exact or unique value of Kf. 20 Thus in most rats, where filtration pressure disequilibrium obtained, unique values of K f could be calculated; in the few rats that remained at filtration pressure equilibrium, minimum estimates of Kf were derived. 20 Mean Kf values for the control study period in groups 1-4 ranged from 0.073 ± 0.005 to 0.076 ± 0.011 nl/(s mm Hg). These were within the range reported previously by us for rats brought to filtration pressure disequilibrium both by plasma volume expansion 20 and isovolemic reduction in hematocrit. 14 Mean values for RA, RE, and RTA are also summarized in Table 1 , and are similar to values reported previously from this laboratory for plasma volume-expanded rats. 22
Group 1. Time Control
As shown in Table 1 , continued volume expansion and vehicle administration failed to significantly influence AP. Arterial hematocrit also was unaffected, averaging 41.5 ± 0.5 vols % in the first study period, and 42.9 ± 0.6 vols % in the second. Whole kidney GFR remained essentially constant, averaging 1.40 ± 0.04 and 1.37 ± 0.04 ml/min in the first and second study periods, respectively. As shown in Table 1 , SNGFR and Q A also remained essentially constant with time, so that values for SNFF also changed little. PGC fell slightly, but significantly, whereas PT remained essentially unchanged, resulting in near-constancy of AP. Pc also remained unchanged with time. C A (and thus n A ) fell significantly with continued volume expansion (Table 1) , and CE (and thus n E ) also fell slightly but not significantly (Table 1 ).
In the first study period, 3 of 6 rats were at filtration pressure disequilibrium, with the ratio of IIE/AP in all six rats averaging 0.93 ± 0.02. In the second period, 5 of 6 rats were at disequilibrium,
TABLE 1 Summary of the Determinants of Single Nephron Function during Control Plasma Volume Expansion, and during Continued Infusion of Vehicle (Group 1), Infusion of a Pressor Dose of A II (Group 2), infusion of a pressor dose of All with Simultaneous Infusion of PG Synthesis Inhibitors (Group 3) and Infusion of PG Synthesis Inhibitors Alone (Group 4)
Group 
Group 2. A II Infusion
As shown in Table 1 and Figure 1 , infusion of A II resulted in a uniform increase in AP, to an average of ~30% above control values (P < 0.001). Arterial hematocrit rose slightly, from 42.6 ± 1.0 to 45.3 ± 1.0 vols % (P < 0.001). Mean values for whole kidney GFR declined slightly, but not significantly, during A II infusion, from an initial mean value of 1.31 ± 0.05 to 1.21 ± 0.09 ml/min. SNGFR also fell slightly, but not significantly, during A II infusion, as shown in Table 1 and Figure 1 . In spite of this near constancy of SNGFR, Q A declined markedly with A II infusion by almost 40% of control ( Fig. 2 and Table 1 ). As a consequence, SNFF rose significantly during infusion of A II (Table 1) . Qualitatively similar findings have been reported earlier when a similar infusion of A II was administered to hydropenic Munich-Wistar rats. 9 ' 10 PGC rose significantly with A II infusion, from 50 ± 1 to 62 ± 2 mm Hg (P < 0.001), whereas P T remained unchanged from initial values ( Table 1) . As a result, AP increased from an initial mean value of 35 ± 1 mm Hg to 47 ± 2 mm Hg with A II (P < 0.001), a mean increase of 34% (Fig. 2) . Mean values for Pc also rose slightly with A II infusion ( Table  1 ). C A , and thus n A , were essentially unaffected by A II infusion, whereas values for C E , and thus n E , showed a significant rise ( Table 1 , P < 0.05). De-spite_this increase in IIE, the concomitant increase in AP was proportionally greater, so that filtration pressure disequilibrium persisted during A II infusion, as indicated by ratios of n E /AP averaging significantly less than unity (0.82 ± 0.04, P < 0.05). Filtration pressure disequilibrium was seen in all rats during A II infusion. Prior to A II, values for Kf in each rat (including two minimum estimates) were higher than during A II infusion, K f averaging 0.074 ± 0.006 and 0.037 ± 0.004 nl/(s-mm Hg), respectively (Table 1 and Fig. 2) . Calculated values for R A , RE, and RTA are given in Table 1 . R A and R E both increased by -100% of initial values during A II infusion; therefore RTA rose by a similar percentage (Fig. 3) . The contribution of RA to RTA, given by the ratio R A /RTA (Table 1) , remained unchanged by A II infusion. Therefore, despite significant A II-induced falls in both Q A and K f , SNGFR fell only slightly, due to 894 CIRCULATION RESEARCH VOL. 43, No. 6, DECEMBER 1978 the offsetting effect of the marked A II-induced increase in AP.
Group 3. A II Infusion during PG Inhibition
In group 3 rats, inhibition of PG synthesis was achieved with indomethacin (I) in four animals and meclofenamate (M) in three; since results for all quantities measured were similar for both PG inhibitors, all data were pooled for statistical evaluations.
As shown in Table 1 and Figure 1 , infusion of A II in rats pretreated with M or I again^resulted in a highly significant mean increase in AP (as in group 2). Hematocrit remained unchanged in this group, averaging 40.5 ± 0.7 vols % in control and 40.8 ± 1.2 vols % with A II. In contrast to group 2 rats, whole kidney GFR declined significantly in group 3 rats, from 1.29 ± 0.07 before, to 0.94 ± 0.09 ml/min during, A II infusion in PG-inhibited rats (P < 0.005). As shown in Table 1 and Figure 1 , SNGFR also fell much more markedly in group 3 than group 2, from 50.9 ± 2.7 to 31.0 ± 2.8 nl/min. Moreover, in group 3 rats, QA declined to a proportionately greater extent, from 164.7 ± 18.9 to 69.3 ± 6.7 nl/min ( Fig. 2 and Table 1 ). As a consequence, SNFF rose significantly (Table 1) .
PGC rose in each rat in group 3, whereas P T remained unaffected by drug infusions (Table 1) . Thus, AP rose significantly, by some 20% of control (Fig. 2) . Mean values for Pc also rose slightly, but significantly, with drug infusion ( Table 1 ). C A (and thus n A ) fell slightly, but significantly, during infusion of A II and PG inhibitor, from 5.2 ± 0.1 g/100 ml (and 16.7 ± 0.4 mm Hg) to 4.8 ± 0.2 g/100 ml (and 14.7 ± 0.8 mm Hg) (P < 0.005). In contrast, values for CE (and thus FIE) rose significantly, on average from 7.8 ± 0.2 g/100 ml (and 30.5 ± 1.5 mm Hg) to 8.7 ± 0.2 g/100 ml (and 36.4 ± 1.7 mm Hg) (P < 0.025). Filtration pressure disequilibrium ob- tained in 6 of 7 rats during the initial study period in group 3 animals, with I I E / A P averaging 0.85 ± 0.05. During infusion of A II and PG inhibitor, this ratio was essentially unchanged (Table 1) . Mean calculated values for Kf averaged 0.073 ± 0.005 nl/(s mm Hg) during the initial study period and fell uniformly and significantly to 0.029 ± 0.003 nl/(smm Hg) during infusion of A II and PG inhibitor (P < 0.001). As shown in Figure 2 , the percentage change in Kf in response to A II in groups 2 and 3 were similar. In group 3 rats, the increases in R A and RE with A II were much greater than in group 2 ( Table 1) , and the increase in RTA in group 3 was more than twice that observed in group 2 (Fig. 3) . Thus, in group 3 rats, SNGFR (and total GFR) fell markedly during A II infusion, whereas infusion of the same dose of A II in group 2 rats had essentially no effect on these quantities. These decreases in SNGFR and total GFR were the consequence mainly of additional increases in arteriolar resistances, RA and R E , and marked declines in QA relative to group 2.
Group 4. PG Inhibition Alone
Experiments to investigate the effect on glomerular dynamics of PG inhibition alone were carried out in four rats given I and in three rats given M. Since results were similar for all quantities measured, all values were pooled. As shown in Table 1 and Figure 1 , PG inhibition failed to change the mean value of AP. Arterial hematocrit also failed to change following PG inhibition, averaging 41.2 ± 0.8 vols % before and 41.3 ± 1.2 vols % during infusion of I or M. Whole kidney GFR also remained essentially unchanged (Fig. 1) , averaging 1.23 ± 0.09 ml/min before and 1.15 ± 0.05 ml/min during inhibition of PG synthesis. Further, the mean value for SNGFR was unaffected by PG inhibition, averaging 45.1 ± 3.8 nl/min and 41.3 ± 3.0 nl/min, respectively. In spite of the relative constancy of SNGFR, Q A fell significantly (Fig. 2) , from a preinfusion mean value of 142.3 ± 24.8 nl/min to 96.6 ± 11.0 nl/min (P < 0.05). Accordingly, SNFF rose significantly ( Table 1) .
PGC and PT remained largely unaffected_by PG inhibition (Table 1) ; thus mean values for AP were also unchanged ( Fig. 2) , averaging 37 ± 1 mm Hg before, and 37 ± 1 mm Hg during, I or M. As shown in Table 1 , mean values for Pc were unaffected by PG inhibition. As in group 1, C A (and thus n A ) fell significantly during PG inhibition, from 5.4 ± 0.2 g/100 ml (and 17.5 ± 0.7 mm Hg) to 4.9 ± 0.1 g/100 ml (and 15.0 ± 0.3 mm Hg) (P < 0.01). Values for C E (and thus n E ) rose slightly, but not significantly, with PG inhibition, in contrast to the significant increases observed in group 3 rats given A II and a PG inhibitor. Nevertheless, this slight rise in C E (from 8.3 ± 0.2_to 8.6 ± 0.2 g/100 ml) together with the failure of AP to change was sufficient to result in filtration pressure equilibrium in 5 of 7 volume-A II AND PG INTERACTIONS ON GLOMERULAR DYNAMICS/Btry/is and Brenner 895 expanded rats. Accordingly, the average value of n E /AP rose from a mean value of 0.92 ± 0.03 (a value significantly less than unity, P < 0.05) in the initial study period to 0.98 ± 0.04 (a value not significantly different from unity) during PG inhibition. Kf did not change significantly during PG inhibition (Table 1; Fig. 3 ). Significant and proportional increases in R A and RE were observed with PG inhibition (Table 1) , although the magnitude of these increases was almost half that of A II alone. RTA also rose by about 50% during PG inhibition (Fig. 3) . The ratio R A /RTA did not differ before and during PG inhibition ( Table 1) .
Comparison between Experimental Groups during Drug Administration
Values AP, PGC, PT, and Pc were essentially similar between group 2 rats (during A II infusion) and group 3 rats (during infusion of AII + PG inhibitor). During PG inhibition alone (group 4), however, mean values for AP, P G c, and Pc were significantly lower than in group 2 (P < 0.005, < 0.001, and < 0.025, respectively), whereas values_for PT were not significantly different. Values of AP, PGC, and PT also were lower in group 4 compared to group 3 rats (P < 0.005, < 0.001, and < 0.01), and the mean value of P T also was significantly lower in group 4 vs. group 2 (P < 0.05). Mean values of CA and CE (and n A and n E ) were similar between groups 2, 3, and 4, although the ratio ITE/AP was significantly higher with PG inhibition alone (group 4, =1.0) compared to groups 2 (P < 0.025) and 3 (P <_O025). No difference in the average value of IIE/AP was observed between groups 2 and 3.
Mean values of SNGFR and Q A were not significantly different during A II infusion (group 2) and infusion of PG inhibitor alone (group 4). However in group 3 rats, during AII infusion + PG inhibition, SNGFR and Q A were significantly lower than in both group 2 and group 4 (P < 0.05 for both variables). There was no statistically significant difference in the mean values of SNFF in groups 2, 3, and 4.
The reduction in Kf that occurred during A II infusion was similar with or without simultaneous inhibition of PG synthesis (groups 2 and 3). In group 4 rats, however, Kf was not reduced by infusion of PG synthesis inhibitors and was thus significantly higher than in either group 2 (P < 0.005) or group 3 (P < 0.001).
The calculated values of R A , RE, and RTA were, on average, significantly higher in group 3 rats than in either group 2 (P < 0.05 for all three variables) or group 4 (P < 0.01, < 0.025, and < 0.01, respectively). In group 2 rats, A II infusion alone resulted in slightly but not significantly higher values of R A , RE, and RTA compared to rats receiving PG inhibitor alone (group 4). No differences were seen in the ratio of R A /RTA in groups 2, 3, and 4.
Discussion
In the present studies, administration of pressor doses of A II to plasma volume-expanded_rats resulted in highly significant increases in AP, due entirely to increases in PGC-There were proportionately smaller but statistically significant increases in n E , whereas n A remained unaffected. The highly significant increase in SNFF with A II (Table 1) corresponded to a significant reduction in Q A in the absence of appreciable change in SNGFR. These findings are qualitatively similar to those reported earlier from this laboratory with similar doses of A II in normal hydropenic rats. 9 ' 10 Because the present studies were carried out against a background of constant plasma volume expansion, however, values for Q A (and SNGFR) were higher than in these earlier studies. Of importance also, filtration pressure disequilibrium obtained both before and during A II adminstration in most of the plasma-ex-panHed rats in the present study. Given filtration pressure disequilibrium, unique values for K f could be calculated. 20 As shown in Table 1 and Figure 2 , Kf fell with AII infusion to ~50% of values obtained prior to A II. This reduction in Kf is quantitatively similar to that reported by Blantz et al." using añ 10-fold lower dose of A II in similarly volumeexpanded rats, suggesting that a maximal effect of A II on K f was obtained in the present study.
The fall in Kf with A II observed in the present study could not be documented by us previously, 9 ' 10 since in these earlier experiments the persistence of filtration pressure equilibrium prevented calculation of unique values of Kf with A II infusion. The value of Kf observed in the present study during A II infusion is, however, high enough to yield filtration pressure equilibrium in the hydropenic A IIinfused rat. Using the mathematical model for glomerular ultrafiltration derived by Deen et al., 18 and the pressures and flows measured previously in hydropenic A II-infused rats, 9 ' 10 but assuming the average of unique Kf values observed with A II in the present study, calculated values for SNGFR are consistent with mean values actually observed in hydropenic A II-infused rats ( Table 2 ).
In hydropenia, where filtration pressure equilibrium obtains both before and during A II infusion, it is not possible to ascertain whether Kf falls with exogenous A II administration, to a value of ~0.04 nl/(s-mm Hg), from some higher value prior to A II infusion. Alternatively, it is possible that during normal hydropenia (together with attendant surgical stresses and anesthesia) endogenous A II levels already are sufficiently high in the pre-A II infusion period to exert a maximal effect on K f , such that infusion of added quantities of AII fails to diminish Kf further. In any event so long as filtration pressure equilibrium is achieved, as in hydropenia, Kf will not be a functionally important determinant of SNGFR or GFR. At disequilibrium, as in plasma 896 CIRCULATION RESEARCH VOL. 43, No. 6, DECEMBER 1978 Calculated values of SNGFR were computed with the observed pressures and flows (shown below) but employing the mean of unique values of K f observed in the volume-expanded, A II-infused rat. volume expansion, however, changes in Kf not offset by changes in the other determinants of SNGFR would be expected to influence filtration rate appreciably, 18 as, for example, in the case of rats after PG inhibition and given A II in the present study.
A II stimulates the release of PGs from a variety of vascular beds. 1 " 5 This release of PGs by A II probably occurs via a stimulus to increased PG synthesis; indeed, Danon et al. 2 have demonstrated that in the rat renal papilla, A II enhances PG synthesis by increasing the availability of free arachidonic acid, the main precursor in the PG biosynthetic pathway. In view of this evidence it seemed appropriate to investigate whether glomerular function in response to AII infusion is modified or influenced by concurrent endogenous PG production. Accordingly, PG production in A II-infused rats was largely prevented by administration of I or M, drugs known to inhibit PG synthesis dramatically at the dose employed. 6 Although no estimates were made of PG activity in plasma and urine during infusion of I or M in the present study, Leyssac et al. 23 have shown that infusion of I, in a dose of ~1 mg/kg body wt per hr, to the anesthetized rat, resulted in marked reduction in renal venous PGE levels (to ~40% of control) within 45 minutes of beginning the infusion. It seems reasonable to assume, therefore, that in the present studies in which a greater dose of I or M was infused, significant inhibition of PG synthesis was achieved.
In the present studies, whereas A II infusion alone failed to significantly alter total GFR or SNGFR, similar doses of A II given during simultaneous inhibition of PG synthesis resulted in marked reductions in both SNGFR and total GFR. During inhibition of PG synthesis, A II infusion also evoked a greater decline in Q A , and a far greater increase in renal arteriolar resistances than occurred with the same dose of A II alone. Thus, the decreases in GFR and SNGFR which occurred with A II in PG-inhibited rats were the consequence of additional increases in afferent and efferent renal arteriolar resistances, leading primarily to greater decreases in Q A , than occurred with A II alone.
In accordance with the observations of the present study, other workers also have reported that PG inhibition leads to a marked enhancement of the A II vasoconstrictor effect on the kidney, and other vascular beds of the dog and rat. 4 ' 7 ' 8 As a result of these and other studies, it is now believed that PGs, released in response to A II infusion, vasodilate certain vascular beds, thereby attenuating the vasoconstrictor actions of A n. ll4l7>8 The present study suggests that, in addition to renal and glomerular blood flow, the response in the rat of SNGFR and total GFR to exogenous A II also is attenuated by endogenous PGs, since PG inhibition leads to significant falls in filtration rate with a dose of A II which, when given alone, has little effect on glomerular filtration rate. In contrast to our observations, however, Malik and coworkers have reported that the PGs themselves exert a vasoconstrictor action on the renal and mesenteric circulation of the rat. 24 ' 25 This is opposed to the rabbit microvasculature where the PGs are vasodilator. On the basis of these studies, carried out on isolated perfused kidneys and mesenteric arteries, Malik et al. concluded that there is a species difference in the effects of PGs on renal (and mesenteric) blood vessels, with the rat being unusual in that the normally vasodepressor PGs are, in the rat, vasoconstrictors. This conclusion seems unlikely, however, since in previous studies we demonstrated that infusion of exogenous PGEi to the intact rat led to vasodilation of the superficial cortical renal microcirculation. 13 In addition, Finn and Arendshorst 7 have reported that I infusion, in the intact rat, caused reduction in renal plasma flow rate, an event consistent with a vasodilator action of endogenous PGs in this species. It seems most likely, therefore, that the observations of Malik and coworkers 24 of a vasoconstrictor action of PGs on the isolated perfused renal vascular bed of the rat are not applicable to the intact rat renal circulation and reflect some separate phenomenon, probably related to their use of an isolated perfused preparation.
In view of the evidence discussed above, together with the observations of the present study, it seems likely that endogenously formed PGs exert a vasodilator action on the microvasculature of the rat superficial renal cortex and also influence superficial SNGFR and whole kidney GFR. No effort was made in this study to ascertain the origin(s) of these endogenous PGs. Although the kidney itself is a major site of PG synthesis and is known to produce PGs in response to A II infusion, other vascular beds have been shown to share this capacity as well. 1 " 5 Furthermore, approximately one-third of all endogenously formed PGs of the E series, and a higher proportion of PGA together with the vasodilator prostacyclin PGI2, appear to escape metab-A II AND PG INTERACTIONS ON GLOMERULAR DYNAMICS/Baylis and Brenner 897 olism during one pass through the lungs, 26 ' 27 a site of high activity of PG-degrading enzymes. 28 Hence, it appears that PGs of both the E and A series are recirculated to a significant extent. Whether the PGs acting on the superficial renal cortical microcirculation in the present study were derived from renal medullary, renal cortical, and/or extrarenal sites remains to be established.
As well as being of unknown origin, the precise nature of the PGs which attenuate the action of A II on the renal microcirculation is unknown. The PG inhibitor, I, has many actions in addition to inhibiting the conversion of arachidonic acid to the PG endoperoxide, PGG 2 (the first step in PG biosynthesis), by blocking the action of the cyclooxygenase enzyme. 6 Since M, another structurally dissimilar inhibitor of the cyclooxygenase dependent step in arachidonic acid metabolism, 6 also was employed in this study, and, since the effects of M were similar to those of I, it seems most likely that the results observed were due to inhibition of the cyclooxygenase enzyme. It has recently become apparent that the PGs A and E are not the only vasoactive products of the arachidonic acid-PG endoperoxide biosynthetic system. Other important products include the unstable potent vasodilator, PGI2, 29 and the thromboxanes, A 2 and B 2 , which are vasoconstrictor at least in some circumstances. 30 Clearly, in the present study, I and M inhibit some vasodilator product (s) of arachidonic acid breakdown; however, since both inhibitors block the first step in the arachidonic acid cascade, it is not possible to attribute the vasodilator actions observed to a particular PG.
In addition to attenuating the vasoconstrictor actions of A II, it seemed possible that endogenous PGs might be mediating the fall in Kf observed with A II, in view of our earlier observations that Kf is reduced during exogenous PGEi infusion. 13 This proved not to be the case, however, since, as shown in Figure 2 , the A II-evoked fall in K f persisted even during inhibition of PG synthesis. Furthermore, the magnitude of the fall in Kf was quantitatively similar to that observed in Group 2 rats during infusion of A II alone. Inhibition of PG synthesis alone apparently failed to affect (i.e., increase) the value of K f , despite the fact that infusion of PGE significantly reduces K f . 13 It should be noted, however, that some increase in the true value of Kf, with PG inhibition, may have gone undetected since I-or M-induced falls in QA resulted in the existence of filtration pressure equilibrium (a condition which permits only minimum estimates of Kf 20 ) in five of the seven rats in this group. Alternatively, it may be that the levels of endogenous PGs in the anesthetized plasma volume-expanded rat are not sufficient to exert an action on Kf. Despite our uncertainty regarding the effects of PG inhibition on the value of Kf in these studies, it nevertheless appears that the fall in Kf seen to occur with A II infusion is not mediated by the secondary release of PGs.
It is therefore reasonable to suggest that the decrease in K f observed in the present study was a direct consequence of the actions of A II. In this regard, several groups of workers have demonstrated the existence of binding sites for A II in rat glomerular capillaries. 31 " 34 It is not apparent from the present studies whether A II influences the value of Kf by an action on glomerular capillary hydraulic permeability and/or an action on capillary surface area. However, Sraer et al. 31 have demonstrated that isolated rat glomeruli, exposed to A II, exhibit a reduction in diameter. Also, scanning electron microscope studies by Hornych et al. 35 have indicated that administration of A II results in constriction of glomerular capillary loops of superficial rat glomeruli. Thus, an A II-induced reduction in glomerular capillary surface area may account for the fall in K f observed with A II in the present study, and this possibility deserves further investigation.
Finally, recent studies by Ichikawa and Brenner 36 and Henrich et al. 37 have also demonstrated a protective effect of endogenous PGs on glomerular function under conditions in which endogenous A II levels are elevated. In these studies, the pathophysiological interventions of partial unilateral ureteral obstruction in the rat 36 and hypotensive hemorrhage in the dog 37 were investigated. In both models, inhibition of PG synthesis led to greater falls in SNGFR (and total GFR) and Q A (and renal plasma flow) than occurred in non-PG-inhibited animals. Once again, marked enhancement of the vasoconstrictor actions of A II on the renal microvasculature occurred during PG inhibition. Although not yet tested, the possibility exists that, in other states likely to be associated with high endogenous A II production (i.e., chronic salt depletion, renal artery-stenosis, and other forms of renal ischemia), concomitant PG production might also be of importance in minimizing the resultant disturbances in glomerular function and, in particular, glomerular filtration rate and renal plasma flow rate.
